InvestorsHub Logo
Followers 493
Posts 62722
Boards Moderated 0
Alias Born 08/28/2010

Re: retireat40 post# 48416

Tuesday, 02/19/2019 10:07:11 AM

Tuesday, February 19, 2019 10:07:11 AM

Post# of 70651
Chairman and CEO Richard Hylen stated, “I had recent meetings with the Switzerland based company in Los Angeles and look forward to disclosing the deal in the very near future. Negotiating points include exclusive rights for Europe and a positive revenue stream for our company. Switzerland is more advanced and ahead of the CBD market as compared to the United States, in both commercial and recreational applications, especially in the medical pharmaceutical markets. Our cold-water extraction technology provides the process of removing THC laden trichomes from plant material by washing the material in cold water. Our technology provides an advanced method to agitate the leaf and cause the trichomes to separate from the plant material to create the THC laden water solution which will be filtered through a series of our micron screens. Once filtered, the final product is pure and can be processed. Cold-water extraction is a non-volatile solvent form which makes the resin brittle so it can be easily separated. This process is extremely clean and creates a pure, clean product, high in THC and extremely tasty with no chemical residue.”

http://www.globenewswire.com/news-release/2019/02/19/1734098/0/en/Simlatus-Satel-Group-Proscere-Bioscience-Announces-European-CBD-Contract-Negotiations.html

Richard Hylen, CEO
Tel: (530) 205-3437


Float is 7 million. O/S is 109,777,937 as of 01/31/2019